Parsifal Capital Management, LP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Parsifal Capital Management, LP disclosed 16 US equity positions worth $1.1bn in its Q3 2025 13F filing. The largest position was AVPT at 11.9% of the reported book, followed by ACI and SN. Against the Q2 2025 filing, it opened 5 new positions, added to 4 and reduced 7 among the top 16 holdings.
What did Parsifal Capital Management, LP own in Q3 2025? Top 16 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | AVPT AVEPOINT INC | Technology | 11.9% | $127.9m | 8,522,740 | 61% | added |
| 2 | ACI ALBERTSONS COS INC | Consumer Defensive | 10.9% | $117.5m | 6,709,248 | -5% | reduced |
| 3 | SN SHARKNINJA INC | Consumer Cyclical | 10.4% | $111.8m | 1,083,600 | 2% | added |
| 4 | DLTR DOLLAR TREE INC | Consumer Defensive | 9.2% | $99.3m | 1,052,185 | -22% | reduced |
| 5 | HGV HILTON GRAND VACATIONS INC | Consumer Cyclical | 8.5% | $91.9m | 2,197,280 | -12% | reduced |
| 6 | MMM 3M CO | Industrials | 8.4% | $90.6m | 583,858 | -18% | reduced |
| 7 | GXO GXO LOGISTICS INCORPORATED | Industrials | 7.3% | $78.4m | 1,482,957 | 77% | added |
| 8 | GMED GLOBUS MED INC | Healthcare | 5.9% | $63.2m | 1,104,332 | 30% | added |
| 9 | ATMU ATMUS FILTRATION TECHNOLOGIE | Consumer Cyclical | 5.2% | $56.0m | 1,243,020 | -29% | reduced |
| 10 | UNH UNITEDHEALTH GROUP INC | Healthcare | 5.0% | $53.4m | 154,600 | -16% | reduced |
| 11 | SXT SENSIENT TECHNOLOGIES CORP | Basic Materials | 4.4% | $46.8m | 498,500 | – | new |
| 12 | LPX LOUISIANA PAC CORP | Industrials | 4.3% | $46.2m | 519,600 | – | new |
| 13 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 3.8% | $40.6m | 2,010,507 | -31% | reduced |
| 14 | IESC IES HLDGS INC | Industrials | 2.4% | $25.8m | 64,800 | – | new |
| 15 | CVS CVS HEALTH CORP | Healthcare | 1.3% | $13.7m | 182,300 | – | new |
| 16 | HUM HUMANA INC | Healthcare | 1.1% | $11.4m | 44,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.